Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Impact Of SARS-CoV-2 Pandemic On The Diagnosis Of Cervical Cancer And Precursor Lesions - A Single Center Retrospective Study

Lavinia Balan
,
Cristina Secosan
* ORCID logo ,
Virgiliu-Bogdan Sorop
,
Marilena Pirtea
,
ANCA MARIA CIMPEAN
,
Daniela Chiriac
,
Catalin Balan
,
Ema Borsi
,
Ariana Iorga
,
Laurentiu Pirtea
Version 1 : Received: 4 April 2024 / Approved: 4 April 2024 / Online: 4 April 2024 (10:59:38 CEST)

How to cite: Balan, L.; Secosan, C.; Sorop, V.-B.; Pirtea, M.; CIMPEAN, A. M.; Chiriac, D.; Balan, C.; Borsi, E.; Iorga, A.; Pirtea, L. Impact Of SARS-CoV-2 Pandemic On The Diagnosis Of Cervical Cancer And Precursor Lesions - A Single Center Retrospective Study. Preprints 2024, 2024040371. https://doi.org/10.20944/preprints202404.0371.v1 Balan, L.; Secosan, C.; Sorop, V.-B.; Pirtea, M.; CIMPEAN, A. M.; Chiriac, D.; Balan, C.; Borsi, E.; Iorga, A.; Pirtea, L. Impact Of SARS-CoV-2 Pandemic On The Diagnosis Of Cervical Cancer And Precursor Lesions - A Single Center Retrospective Study. Preprints 2024, 2024040371. https://doi.org/10.20944/preprints202404.0371.v1

Abstract

Objective: The aim of our study was to perform a retrospective analysis of the volume of cervical screening tests, the number of patients treated with an excision method, and the incidence of invasive and non-invasive cervical during a pandemic and pre-pandemic period of 24 months. Results: There was a statistically significant age difference between the two study periods, both by the average age of patients and by age group. The mean difference was 32 years before the pan-demic and 35 years during the pandemic (p-value >0.05). The majority of patients presenting for investigations before and during the pandemic were in the 30-39-year-old age group (31.95%, respectively; 34.2% (p-value = 0.003). The biggest patient loss ratio identified by age group was in the 50–59 years: 14,53% in the pre-pandemic period and 9,1% in the pandemic period. In the pan-demic period, patients from rural areas presented in the clinical trial with a lower rate of 39.52% (83 patients) vs. 60.47% (127 patients) in urban areas. A higher percentage of patients experiencing cervicorrhagia as a clinical manifestation in the pandemic period vs. the prepandemic period, with an increase in more severe lesions in the pandemic period, has a statistical significance of 8% more newly diagnosed compared to the pre-pandemic period. Conclusion: The addressability of the patients during the COVID period was not affected in a drastic way in our study. We encountered a decrease in appointments in the age group 50–59 years and a decrease in patients with rural residence. In our study, we found an increase in cervicorrhagia as a reason for consultation in the pandemic period with a higher lesion degree, both on a pap smear and on a cervical biopsy.

Keywords

covid-19; sars-cov-2; cancer diagnosis; conization; cervical cancer; colposcopy; dysplasia; biopsy

Subject

Medicine and Pharmacology, Obstetrics and Gynaecology

Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Download PDF

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0
Get PDF Cite Share 0
Bookmark BibSonomy Mendeley Reddit Delicious
×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.